The Effectiveness of the Use of Oxygen Reserve Index in Preventing Hyperoxia in the Intensive Care Unit.
Determination of the Incidence of Hyperoxia and the Effectiveness of FiO2 Titration Guided by the Oxygen Reserve Index in Preventing Hyperoxia in Mechanically Ventilated Patients in the Intensive Care Unit.
1 other identifier
interventional
60
1 country
1
Brief Summary
Oxygen therapy is the most common treatment modality for patients with hypoxemia in intensive care units, but target values for normoxemia are not clearly defined. Therefore, iatrogenic hyperoxemia is a very common situation. In intensive care units, FiO2 is usually adjusted according to hypoxia and hyperoxia is ignored in patients under mechanical ventilator support. Even though there are many side effects reported related to hyperoxemia and hyperoxemia is shown to be related to worse outcome than expected; clinicians still observe hyperoxemia frequently. Continuous ORi monitoring can be used for detecting and preventing hyperoxia. The ability to perform FiO2 titration with ORi may be an appropriate monitoring management to prevent the harmful effects of hyperoxia. In this study, it was aimed to investigate the effectiveness of ORi-guided FiO2 titration in preventing hyperoxia in patients undergoing mechanical ventilation in the intensive care unit and to determine the incidence of hyperoxia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 13, 2023
CompletedFirst Submitted
Initial submission to the registry
March 15, 2023
CompletedFirst Posted
Study publicly available on registry
April 11, 2023
CompletedApril 11, 2023
March 1, 2023
2 years
March 15, 2023
March 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation of FiO2 and ORi value
Correlation of FiO2 value and ORi value. FiO2 adjusted until ORi reaches to zero and %95\<oxygen saturation≤%98
Up to 24 weeks
Secondary Outcomes (4)
Fraction of inspired oxygen (FiO2)
Up to 48 hours
Mean arterial blood pressure (MAP)
Up to 48 hours
Heart rate (HR)
Up to 48 hours
Positive end-expiratory pressure (PEEP)
Up to 48 hours
Study Arms (2)
Control group
NO INTERVENTIONPatients with oxygen saturation \> 97% will only be observed. ORi values will be recorded blindly from the clinician. Adjustments to be made in FiO2 will be determined by the intensive care doctor independently of the study, and only observation will be made in this group.
ORi+SpO2 (oxygen saturation) group
ACTIVE COMPARATORFraction of inspired oxygen (FiO2) is titrated guided by oxygen saturation in that range; %95\<oxygen saturation≤%98
Interventions
FiO2 will be titrated by reducing 10% if Ori\>0.01 and oxygen saturation ≥ 98% until Ori is 0.00. FiO2 will not be changed if Ori is 0.00 and %95\<oxygen saturation≤%98 FiO2 will be increased by 10% if oxygen saturation \<95 or PaO2\<60 mmHg
Eligibility Criteria
You may qualify if:
- Patients older than 18 years,
- Patients whose oxygen saturation \>97%
- Patients that have invasive arterial monitorization
You may not qualify if:
- Patients younger than 18
- Patients that need to be treated with high doses of vasopressors,
- Patients having peripheric hypoperfusion,
- Hemodynamically unstable patients,
- Patients with hemoglobinopathy,
- Pregnancy,
- Morbid obesity (bmi\>40 kg/m2),
- Patients with arrythmia that can result in hemodynamic instability, patients with acute coronary syndrome
- Acute respiratory failure or ARDS.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tepecik Research and Training Hospital
Izmir, Konak, 35110, Turkey (Türkiye)
Related Publications (5)
de Graaff AE, Dongelmans DA, Binnekade JM, de Jonge E. Clinicians' response to hyperoxia in ventilated patients in a Dutch ICU depends on the level of FiO2. Intensive Care Med. 2011 Jan;37(1):46-51. doi: 10.1007/s00134-010-2025-z. Epub 2010 Sep 28.
PMID: 20878146BACKGROUNDRincon F, Kang J, Maltenfort M, Vibbert M, Urtecho J, Athar MK, Jallo J, Pineda CC, Tzeng D, McBride W, Bell R. Association between hyperoxia and mortality after stroke: a multicenter cohort study. Crit Care Med. 2014 Feb;42(2):387-96. doi: 10.1097/CCM.0b013e3182a27732.
PMID: 24164953BACKGROUNDMach WJ, Thimmesch AR, Pierce JT, Pierce JD. Consequences of hyperoxia and the toxicity of oxygen in the lung. Nurs Res Pract. 2011;2011:260482. doi: 10.1155/2011/260482. Epub 2011 Jun 5.
PMID: 21994818BACKGROUNDScheeren TWL, Belda FJ, Perel A. Correction to: The oxygen reserve index (ORI): a new tool to monitor oxygen therapy. J Clin Monit Comput. 2018 Jun;32(3):579-580. doi: 10.1007/s10877-018-0104-9.
PMID: 29445905BACKGROUNDYoshida K, Isosu T, Noji Y, Ebana H, Honda J, Sanbe N, Obara S, Murakawa M. Adjustment of oxygen reserve index (ORi) to avoid excessive hyperoxia during general anesthesia. J Clin Monit Comput. 2020 Jun;34(3):509-514. doi: 10.1007/s10877-019-00341-9. Epub 2019 Jun 22.
PMID: 31227971BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associated professor
Study Record Dates
First Submitted
March 15, 2023
First Posted
April 11, 2023
Study Start
March 1, 2021
Primary Completion
March 1, 2023
Study Completion
March 13, 2023
Last Updated
April 11, 2023
Record last verified: 2023-03